منابع مشابه
Acute cardiac failure after sunitinib.
Acute cardiac failure after sunitinib A 54-year-old male with cytokine-refractory metastatic renal cell carcinoma was admitted because of respiratory distress and hypotension. Five years earlier, he has been treated with alpha interferon (IFN) and interleukin-2 (two cycles of 6 weeks, s.c.) for bone, mediastinal lymph node and pulmonary metastases. Six months before admission, sunitinib (50 mg/...
متن کاملacute renal failure after cardiac surgery
acute renal failure (arf) following cardiac surgery occurs in 1 to 10% of patients. patients who develop arf have higher rates of mortality. this study was undertaken to estimate the role of perioperative variables in predicting of post cardiac surgery arf. we studied a cohort of 398 adult patients who underwent cardiac surgery at our institution from february 2004 to february 2006. adult patie...
متن کاملAcute renal failure after treatment with sunitinib in a patient with multiple myeloma
Sunitinib is a multiple tyrosine kinase receptors inhibitor that is approved for the treatment of advanced renal cell carcinoma. Amongst its targets are fetal liver tyrosine kinase receptor 3 (FLT 3) and vascular endothelial growth factor receptor (VEGFR). Renal toxicity has not been reported from the trials, but several patients have been reported to develop a pre-eclampsia-like syndrome. We r...
متن کامل[Acute renal failure after cardiac surgery under extracorporeal circulation].
Acute renal failure (ARF) following cardiac surgery under extra-corporeal circulation is a grave but infrequent complication. Numerous physiopathological factors accounting for its origin are analyzed, those related to ECC and those of the immediate post-operative period. The course of these cares of ARF and the elements of the treatment are looked at.
متن کاملNephrotic Syndrome and Acute Renal Failure Apparently Induced by Sunitinib
We report a case of nephrotic syndrome and acute renal failure apparently induced by sunitinib. A 67-year-old man with a history of metastatic renal cell carcinoma presented with progressive kidney dysfunction with proteinuria, general edema, and body weight gain of 21 kg after undergoing 3 weeks of sunitinib therapy. The patient had taken no other over-the-counter medications, and all other po...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2008
ISSN: 0923-7534
DOI: 10.1093/annonc/mdn019